Expression of thymosin beta-4 was found to have a negative correlation with survival period of patients with non-small cell lung cancer (NSCLC), where the protein expression was associated with increased metastasis and poor prognosis61. This evidence concerns the gene TMSB4X and non-small cell lung carcinoma.